Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Phone781-821-2440
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees36
Next Earnings DateN/A
OptionableNot Optionable
Avitar (OTCMKTS:AVTI) Frequently Asked Questions
What is Avitar's stock symbol?
Avitar trades on the OTCMKTS under the ticker symbol "AVTI."
Has Avitar been receiving favorable news coverage?
Press coverage about AVTI stock has been trending negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Avitar earned a news impact score of -2.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future.
Who are some of Avitar's key competitors?
Some companies that are related to Avitar include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), Wright Medical Group (WMGI), MSA Safety (MSA), Avanos Medical (AVNS), Inogen (INGN), Wound Management Technologies (WNDM), Establishment Labs (ESTA), RTI Surgical (RTIX) and ConforMIS (CFMS).
What other stocks do shareholders of Avitar own?
Who are Avitar's key executives?
Avitar's management team includes the folowing people:
- Mr. Cory H. Gelmon, CEO, Pres, Treasurer & Sec. (Age 59)
How do I buy shares of Avitar?
Shares of AVTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Avitar's stock price today?
One share of AVTI stock can currently be purchased for approximately $0.0004.
What is Avitar's official website?
How can I contact Avitar?
Avitar's mailing address is 65 DAN ROAD, CANTON MA, 02021. The company can be reached via phone at 781-821-2440.
MarketBeat Community Rating for Avitar (OTCMKTS AVTI)
MarketBeat's community ratings are surveys of what our community members think about Avitar and other stocks. Vote "Outperform" if you believe AVTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
